BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 10631075)

  • 1. Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys.
    Puri SK; Singh N
    Exp Parasitol; 2000 Jan; 94(1):8-14. PubMed ID: 10631075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium yoelii: activity of azithromycin in combination with pyrimethamine or sulfadoxine against blood and sporozoite induced infections in Swiss mice.
    Neerja J; Puri SK
    Exp Parasitol; 2004; 107(3-4):120-4. PubMed ID: 15363937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue schizontocidal effect of trifluoroacetyl primaquine in Plasmodium yoelii infected mice and Plasmodium cynomolgi infected monkeys.
    Shao BR; Ye XY
    Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):81-3. PubMed ID: 1948265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Ayush-64 for blood schizontocidal activity against rodent and simian malaria parasites.
    Kazim M; Puri SK; Dutta GP; Narasimham MV
    Indian J Malariol; 1991 Dec; 28(4):255-8. PubMed ID: 1824361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial activity of Floxacrine (HOE 991) I. Studies on blood schizontocidal action of Floxacrine against Plasmodium berghei, P. vinckei and P. cynomolgi.
    Raether W; Fink E
    Ann Trop Med Parasitol; 1979 Dec; 73(6):505-26. PubMed ID: 120142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New adamantane-based spiro 1,2,4-trioxanes orally effective against rodent and simian malaria.
    Singh C; Kanchan R; Sharma U; Puri SK
    J Med Chem; 2007 Feb; 50(3):521-7. PubMed ID: 17266204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causal prophylactic efficacy of primaquine, tafenoquine, and atovaquone-proguanil against Plasmodium cynomolgi in a rhesus monkey model.
    DiTusa C; Kozar MP; Pybus B; Sousa J; Berman J; Gettayacamin M; Im-erbsin R; Tungtaeng A; Ohrt C
    J Parasitol; 2014 Oct; 100(5):671-3. PubMed ID: 24780070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
    Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
    Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood schizontocidal activity of WR 238605 (Tafenoquine) against Plasmodium cynomolgi and Plasmodium fragile infections in rhesus monkeys.
    Puri SK; Dutta GP
    Acta Trop; 2003 Apr; 86(1):35-40. PubMed ID: 12711101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium cynomolgi: gametocytocidal activity of the anti-malarial compound CDRI 80/53 (elubaquine) in rhesus monkeys.
    Puri SK; Dutta GP
    Exp Parasitol; 2005 Sep; 111(1):8-13. PubMed ID: 16005457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causal prophylactic and radical curative activity of WR182393 (a guanylhydrazone) against Plasmodium cynomolgi in Macaca mulatta.
    Corcoran KD; Hansukjariya P; Sattabongkot J; Ngampochjana M; Edstein MD; Smith CD; Shanks GD; Milhous WK
    Am J Trop Med Hyg; 1993 Oct; 49(4):473-7. PubMed ID: 8214277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of causal prophylactic activity in Plasmodium berghei yoelii and its value for the development of new antimalarial drugs.
    Fink E
    Bull World Health Organ; 1974; 50(3-4):213-22. PubMed ID: 4155355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice.
    Siddiqi NJ; Alhomida AS; Dutta GP; Pandey VC
    In Vivo; 2002; 16(1):67-70. PubMed ID: 11980364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood schizontocidal activity of azithromycin and its combination with alpha/beta arteether against multi-drug resistant Plasmodium yoelii nigeriensis, a novel MDR parasite model for antimalarial screening.
    Tripathi R; Dhawan S; Dutta GP
    Parasitology; 2005 Sep; 131(Pt 3):295-301. PubMed ID: 16178350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of the antimalarial activity of a new macrolide antibiotic midecamycin in mice and monkeys.
    Puri SK; Dutta GP
    Chemotherapy; 1989; 35(3):187-92. PubMed ID: 2766859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8-(1-Naphthalen-2-yl-vinyl)-6,7,10-trioxaspiro (4.5) decane, a new 1,2,4-trioxane effective against rodent and simian malaria.
    Singh C; Kanchan R; Srivastava D; Puri SK
    Bioorg Med Chem Lett; 2006 Feb; 16(3):584-6. PubMed ID: 16275088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis.
    Awasthi A; Dutta GP; Bhakuni V; Tripathi R
    Exp Parasitol; 2004; 107(3-4):115-9. PubMed ID: 15363936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malaria causal prophylactic activity of imidazolidinedione derivatives.
    Guan J; Wang X; Smith K; Ager A; Gettayacamin M; Kyle DE; Milhous WK; Kozar MP; Magill AJ; Lin AJ
    J Med Chem; 2007 Nov; 50(24):6226-31. PubMed ID: 17967003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant Plasmodium falciparum.
    Biswas S
    J Postgrad Med; 2001; 47(4):240-3. PubMed ID: 11832638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive live sporozoites inoculation under arteether chemoprophylaxis confers protection against subsequent sporozoite challenge in rodent malaria model.
    Bhardwaj J; Siddiqui AJ; Goyal M; Prakash K; Soni A; Puri SK
    Acta Trop; 2016 Jun; 158():130-138. PubMed ID: 26925772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.